๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The TAILORx trial: individualized options for treatment

โœ Scribed by Joseph A. Sparano


Book ID
118628460
Publisher
Frontline Medical Communications, Inc.
Year
2006
Tongue
English
Weight
124 KB
Volume
3
Category
Article
ISSN
1548-5315

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Individualized treatment duration for he
โœ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Giovanni L ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 269 KB ๐Ÿ‘ 2 views

It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n = 696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b, 1.5 mg/kg/week, p